Cleared by the FDA to treat geographic atrophy, the drug was a key reason Japan’s Astellas bought Iveric for $5.9 billion in May.Published Aug. 5, 2023 Ben FidlerSenior Editor Associated with age-related macular degeneration, geographic atrophy causes irreversible vision loss. Alexander Ford via Getty Images The Food and Drug Administration on Friday approved a second medicine...